Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7310181

Concept 2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,894,000,000 JPY
3,785,000,000 JPY
5,207,000,000 JPY
5,023,000,000 JPY
Non-operating income
Non-operating income
126,000,000 JPY
165,000,000 JPY
86,000,000 JPY
149,000,000 JPY
Non-operating expenses
Non-operating expenses
97,000,000 JPY
79,000,000 JPY
124,000,000 JPY
89,000,000 JPY
Ordinary profit (loss)
3,923,000,000 JPY
3,872,000,000 JPY
5,169,000,000 JPY
5,082,000,000 JPY
Extraordinary income
Extraordinary income
461,000,000 JPY
461,000,000 JPY
12,000,000 JPY
12,000,000 JPY
Extraordinary losses
Extraordinary losses
166,000,000 JPY
165,000,000 JPY
105,000,000 JPY
229,000,000 JPY
Profit (loss) before income taxes
4,218,000,000 JPY
4,168,000,000 JPY
5,076,000,000 JPY
4,866,000,000 JPY
Income taxes - current
902,000,000 JPY
749,000,000 JPY
1,595,000,000 JPY
1,408,000,000 JPY
Income taxes - deferred
138,000,000 JPY
169,000,000 JPY
-46,000,000 JPY
-34,000,000 JPY
Profit (loss)
3,249,000,000 JPY
3,249,000,000 JPY
3,249,000,000 JPY
3,178,000,000 JPY
3,249,000,000 JPY
3,527,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.